An IRIS preventative screening for Diabetic Retinopathy is as simple and quick as taking a patient’s blood pressure or stepping on a scale, and can be just as helpful to physicians in helping to detect eye disease or other disorders. The retina is a window into the body. Minute changes in the blood vessels of the retina can be early indicators of issues elsewhere.
The IRIS team is working with health care providers and payers across the country to simply and affordably provide Diabetic Retinopathy assessments to their diabetic patient populations — conveniently in the primary care setting.
The IRIS board of advisors is comprised of some of the top medical and business thought-leaders in the country. Additionally, IRIS is backed by the resources of United States Retina, a nation-wide affiliation of top retina surgeons and practices. IRIS also works with Lions Eye Institute to provide screenings at events across the southern United States, and works closely with the Florida Institute for Human and Machine Cognition (IHMC) to advance technologies in the healthcare space.